Abstract:Resumo Introdução e objetivos: A estenose aórtica é a doença valvular mais frequente. O número de octogenários propostos para intervenção está a aumentar devido ao aumento da esperança média de vida. Neste artigo pretendemos avaliar os resultados cirúrgicos e sobrevida a longo prazo da cirurgia de substituição de válvula aórtica (SVA) em octogenários, comparando pacientes com baixo risco cirúrgico (EuroscoreII<4%) com risco intermédio-alto (EuroscoreII ≥4%). Métodos: Estudo observacional retrospetivo, centro único, incluindo 195 doentes ≥80 anos, submetidos a SVA entre 2017-2021. Os pacientes foram divididos em dois grupos de acordo com EuroscoreII: baixo risco cirúrgico (EuroscoreII<4%) ou risco intermédio-alto (EuroscoreII≥4%).Variáveis contínua; variáveis categóricas em percentagens, analisadas com teste chi-quadrado. A sobrevivência foi analisada com modelo de Kaplan-Meier, coorte aberto, usando o teste log-rank. Resultados: A mediana de idades foi de 82 (IQR 81-83), com 4,6% dos doentes ≥ 85 anos. 23,6% apresentavam EuroscoreII ≥4%. 26,2% dos doentes não apresentaram complicações, com uma proporção mais alta de complicações nos doentes com risco intermédio-alto. A complicação mais frequente foi a necessidade de suporte hemodinâmico pós-operatório, seguida de lesão renal aguda e de transfusão de produtos hemáticos. O tempo mediano de internamento na UCI foi de três dias (2-4) e hospitalar de seis dias (5-8). Doentes com risco intermédio-alto e com complicações apresentaram internamentos na UCI mais prolongados. A sobrevida global foi de 96,4% aos 12 meses, 94,1% aos três anos e 75,4% aos cinco anos. Conclusão: A SVA em doentes ≥80 anos apresenta mortalidade intra-hospitalar baixa, apesar de uma proporção significativa de pacientes desenvolver complicações. A sobrevida é mais elevada após cinco anos nos pacientes com baixo risco. Introduction and objectives: Aortic stenosis is the most common valvular heart disease. The number of octogenarians proposed for intervention is growing due to increased lifespan. In this manuscript we aim to evaluate perioperative outcome and long-term survival after surgical aortic valve replacement (SAVR) in octogenarians, comparing patients with low surgical risk (EuroscoreII <4%) with intermediate-high risk (EuroscoreII ≥4%). Methods: A retrospective observational single-center cohort study with 195 patients aged ≥80 years-old, who underwent SAVR between 2017-2021. Pantients were divided into two groups according to EuroscoreII: 1) Low risk (EuroscoreII<4%) with intermediate-high risk (EuroscoreII≥4%). Continuous variables are presented in median (IQR), analyzed using Wilcoxon rank sum test; categorical variables in percentages, analyzed using chi-squared test; and survival was analyzed by Kaplan-Meier, open cohort, and the log-rank test was performed. Results: The overall median age was 82 (IQR 81–83), with 4.6% of the patients ≥85years-old. 23.6% of the patients presented EuroscoreII≥4%. No complications were observed in 26.2%, with a significantly higher rate in intermediate-high risk patients. Postoperative need for hemodynamic support was the most frequent complication, followed by postoperative acute kidney injury and the use of blood products. Overall median ICU stay was 3 days (2–4) and hospital length of stay (LOS) 6 days (5–8). Patients with intermediate-high risk and those with complications had longer ICU LOS. At 12 months, overall survival was 96.4%, at 3 years 94.1% and 5 years 75.4%. Patients with low surgical risk had higher survival proportions up to 5 years. Conclusion: SAVR in patients ≥80yo is associated with low in-hospital mortality, although a significant proportion of patients develop complications. Long-term follow-up up to 5 years after surgery is acceptable in octogenarians with low surgical risk.

Aortic valve replacement in patients older than 85 years: outcomes and the effect on their quality of life

Aortic Valve Replacement In Elderly Patients: Influence Of Concomitant Coronary Grafting On Late Survival

Quality of life in octogenarians after valve replacement due to aortic stenosis. A prospective comparison with younger patients

Early and long-term survival after aortic valve replacement in septuagenarians and octogenarians with severe aortic stenosis

How to approach aortic valve disease in the elderly: a 25-year retrospective study

Aortic valve replacement in elderly patients:Surgical risk and outcome

[Severe Aortic Valve Stenosis and Coronary Disease in the Elderly. Epidemiology and Hemodynamic Features].

Long-term outcomes following aortic valve replacement in bioprosthetic vs mechanical valves

Cost-effectiveness of aortic valve replacement in the elderly: an introductory study

The Impact of Aortic Valve Replacement on Survival in Patients with Normal Flow Low Gradient Severe Aortic Stenosis: a Propensity-Matched Comparison.

Short-term outcomes after surgical aortic valve replacement in elderly patients - results of a comparative cohort study

Association between surgical aortic valve replacement and long-term outcomes in 50 to 65-year-olds: Results of the AUTHEARTVISIT study

Long-term survival and outcomes according to age for patients underwent to transcatheter aortic valve replacement

Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies

Surgical aortic valve replacement in octogenarians: single-center perioperative outcomes and 5-years survival

Minimally Invasive and Full Sternotomy Aortic Valve Replacements Lead to Comparable Long-Term Outcomes in Elderly Higher-Risk Patients: A Propensity-Matched Comparison

Age-Based Outcomes After Surgical Aortic Valve Replacement With Bioprosthetic Versus Mechanical Valves

Trends in Transcatheter and Surgical Aortic Valve Replacement Among Older Adults in the United States

Aortic-Valve Replacement - Determinants of Operative Mortality

Thirty-year outcomes of low-intensity anticoagulation for mechanical aortic valve

Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trial